Kalaris Therapeutics (KLRS) Shares Outstanding (Entity) (2019 - 2026)
Kalaris Therapeutics' Shares Outstanding (Entity) was 23.8 million in Q2 2026, up 27.3% from 18.7 million a year earlier and up 3.5% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at Kalaris Therapeutics came in at 15.27 million, up 204.8% from FY2024.
- Shares Outstanding (Entity) shows a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Entity) was 5.01 million in FY2024 (-95.6%), 114.15 million in FY2023 (+48.9%), 76.65 million in FY2022 (+20.6%) and 63.57 million in FY2021 (+136.3%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) since Q3 2024.
- Compared with a year earlier, Shares Outstanding (Entity) has increased for three straight quarters, with growth averaging 42.6% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding (Entity) over five years was Q1 2026 (growth of 467.3%); the worst was Q1 2025 (a decline of 96.5%).
- Per Business Quant data, KLRS's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 22.99 million (Q1 2026), 15.27 million (Q4 2025) and 18.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | 23.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.80 Mn |
| Mar 31, 2026 | 22.99 Mn |
| Dec 31, 2025 | 15.27 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 18.70 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Sep 30, 2024 | 115.44 Mn |
| Jun 30, 2024 | 115.31 Mn |
| Mar 31, 2024 | 114.88 Mn |
| Dec 31, 2023 | 114.15 Mn |
| Sep 30, 2023 | 113.97 Mn |
| Jun 30, 2023 | 94.63 Mn |
| Mar 31, 2023 | 93.43 Mn |
| Dec 31, 2022 | 76.65 Mn |
| Sep 30, 2022 | 92.64 Mn |
| Jun 30, 2022 | 64.79 Mn |
| Mar 31, 2022 | 64.26 Mn |
| Dec 31, 2021 | 63.57 Mn |
| Sep 30, 2021 | 63.18 Mn |
API Access
Kalaris Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();